Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

Coming off Ozempic or similar GLP-1 medications like ... It was more just taking on board what I learnt and felt when I was on 'The Pen' (the colloquial term for the weekly jabs) and I've just ...

From ‘Ozempic face’ to ‘Ozempic fingers’ and even ‘Wegovy butt,’ the potential side effects of weight loss medications have been well-documented. But now, a new study has revealed yet ...

A federal judge in Texas late Thursday rejected a bid by compounding pharmacies to keep making copies of Ozempic and Wegovy while a legal challenge over the shortage of those drugs unfolds.

April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal ...

DALLAS — A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal ...

The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes medication Ozempic secured a court victory that limits compounding pharmacies from selling versions of those ...

A few accused her of being on the trendy weight loss drug used by multiple celebs, Ozempic. 'Ozempic queen,' one wrote. 'She's so skinny! I like her when she was thicker. Everybody's getting on ...

70. Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy.

However, the post also sparked speculation that songwriter-singer has used the trendy weight loss drug Ozempic. One social media user wrote, "Ozempic queen." Second internet user commented ...

Semaglutide injections like Ozempic have taken the world by storm—praised for their blood sugar-regulating powers and unintended weight loss effects. But while headlines focus on shrinking ...